The newest Canadian Licensed Producer to begin trading publicly is ABcann Global, which is expected to resume trading tomorrow, May 4, 2017 following today's closing of their qualifying reverse merger transaction. Shares of ABcann Global will be trading on the TSX Venture Exchange under the symbol "ABCN", and if recent interest in newly listed cannabis stocks is any indication, investor demand should be significant.
ABcann Global's wholly-owned subsidiary, ABcann Medicinals, is licensed under Health Canada's ACMPR to cultivate and sell cannabis at its facility located in Napanee, Ontario. ABcann Medicinals was initially licensed in March 2014 and has both sale and cultivation licenses. According to the company's investor presentation their current facility is 14,500 square feet and is able to produce 1000 kilograms per year. Additionally, ABcann is about to begin construction of their planned 71,000 square foot facility that has a estimated annual production capacity of 20,000 kg.
We'll be keeping on eye on the markets tomorrow to see how shares of ABcann Global open, and we'll be sure to keep you posted with any developments. Happy Trading!
I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.
This site has been designed for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced upon the site. The services and information provided through this site are for personal, non-commercial, educational use and display. www.dailymarijuanaobserver.com does not provide investment advice through this site and does not represent that the securities or services discussed are suitable for any investor. Investors are advised not to rely on any information contained in the site in the process of making a fully informed investment decision.